Funder: Institute of Translational Health Sciences
Due Dates (Anticipated): August 2027 (Letter of Intent) | October 2027 (Full application)
Funding Amounts: Up to $50,000 in total costs for up to one year
Summary: Supports development of generalizable translational tools and methodologies for preclinical research, therapy discovery, and clinical efficacy monitoring.
Key Information: Tools must generalize within translational science; proposals without demonstrated generalizability are nonresponsive.
Description
The Institute of Translational Health Sciences (ITHS) offers this pilot award to develop computational, biochemical, biological, and engineering-based tools that advance new therapies and treatment approaches. It supports preclinical development and evaluation of therapies, treatments, and devices, as well as tools for real-time monitoring of clinical efficacy, such as wearables.
The program emphasizes interdisciplinary translational science that improves research speed, quality, cost-effectiveness, and reach. Priority areas include microfluidics, organoids and tissue chips, integrated robotics, AI-based drug design and discovery, and biomarker analysis. Projects advancing drug, device, and biomarker discovery are strongly encouraged, including methods that reduce or replace animal testing. The goal is to incubate generalizable solutions to common, persistent research challenges rather than tools confined to one application.
